AAAAAA

   
Results: 1-25 | 26-33 |
Results: 26-33/33

Authors: HARRIS JD HURST H LEMOINE N SIKORA K
Citation: Jd. Harris et al., A TUMOR-SPECIFIC PRODRUG ACTIVATION STRATEGY FOR BREAST AND PANCREATIC-CANCER, Journal of cellular biochemistry, 1994, pp. 238-238

Authors: SIKORA K
Citation: K. Sikora, FIRST 5 YEARS OF GENE-THERAPY FOR CANCER, Lancet, 344(8937), 1994, pp. 1631-1631

Authors: SIKORA K
Citation: K. Sikora, CAN HAMMERSMITH-HOSPITAL BE SAVED, Lancet, 343(8896), 1994, pp. 544-544

Authors: BASHIR I SIKORA K ABEL P FOSTER CS
Citation: I. Bashir et al., ESTABLISHMENT AND IN-VIVO CHARACTERIZATION OF MULTIDRUG-RESISTANT DUNNING R3327 RAT PROSTATE-CARCINOMA CELL-LINES, International journal of cancer, 57(5), 1994, pp. 719-726

Authors: WASAN HS SCHOFIELD JB KRAUSZ T SIKORA K WAXMAN J
Citation: Hs. Wasan et al., COMBINED CHORIOCARCINOMA AND YOLK-SAC TUMOR ARISING IN BARRETTS-ESOPHAGUS, Cancer, 73(3), 1994, pp. 514-517

Authors: PANDHA HS WAXMAN J SIKORA K
Citation: Hs. Pandha et al., BIOCHEMICAL PROFILES - TUMOR-MARKERS, British Journal of Hospital Medicine, 51(6), 1994, pp. 297

Authors: BASHIR I SIKORA K FOSTER CS
Citation: I. Bashir et al., MULTIDRUG-RESISTANCE AND BEHAVIORAL-PHENOTYPE OF CANCER-CELLS, Cell biology international, 17(10), 1993, pp. 907-917

Authors: OROURKE N PRICE PM KELLY S SIKORA K
Citation: N. Orourke et al., TUMOR INOCULATION DURING LAPAROSCOPY, Lancet, 342(8867), 1993, pp. 368-368
Risultati: 1-25 | 26-33 |